Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Analyst Ratings

Where Ligand Pharmaceuticals Stands With Analysts

By Benzinga Insights
September 19, 1:00 PM
Over the past 3 months, 4 analysts have published their opinion on Ligand Pharmaceuticals (NASDAQ:LGND) stock. These analysts…

LGND

Read More
1 minute read
  • Analyst Ratings

What 5 Analyst Ratings Have To Say About Invitation Homes

By Benzinga Insights
September 19, 1:00 PM
Within the last quarter, Invitation Homes (NYSE:INVH) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

INVH

Read More
2 minute read
  • Analyst Ratings

What 6 Analyst Ratings Have To Say About Clorox

By Benzinga Insights
September 19, 1:00 PM
Analysts have provided the following ratings for Clorox (NYSE:CLX) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

CLX

Read More
1 minute read
  • Analyst Ratings

Evercore ISI Group Maintains Outperform Rating for Travere Therapeutics: Here’s What You Need To Know

By Benzinga Insights
September 19, 1:00 PM
Evercore ISI Group has decided to maintain its Outperform rating of Travere Therapeutics (NASDAQ:TVTX) and raise its price…

TVTX

Read More
1 minute read
  • Analyst Ratings

Mizuho Maintains Buy Rating for Coterra Energy: Here’s What You Need To Know

By Benzinga Insights
September 19, 1:00 PM
Mizuho has decided to maintain its Buy rating of Coterra Energy (NYSE:CTRA) and raise its price target from…

CTRA

Read More
1 minute read
  • Analyst Ratings

Expert Ratings for CrowdStrike Holdings

By Benzinga Insights
September 19, 1:00 PM
Within the last quarter, CrowdStrike Holdings (NASDAQ:CRWD) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

CRWD

Read More
1 minute read
  • Analyst Ratings

HC Wainwright & Co. Maintains Buy Rating for Hecla Mining: Here’s What You Need To Know

By Benzinga Insights
September 19, 1:00 PM
HC Wainwright & Co. has decided to maintain its Buy rating of Hecla Mining (NYSE:HL) and lower its…

HL

Read More
2 minute read
  • Analyst Ratings

Analyst Ratings for B&G Foods

By Benzinga Insights
September 19, 1:00 PM
Within the last quarter, B&G Foods (NYSE:BGS) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

BGS

Read More
1 minute read
  • Analyst Ratings

Roth MKM Maintains Neutral Rating for Hecla Mining: Here’s What You Need To Know

By Benzinga Insights
September 19, 1:00 PM
Roth MKM has decided to maintain its Neutral rating of Hecla Mining (NYSE:HL) and lower its price target…

HL

Read More
2 minute read
  • Analyst Ratings

BTIG Maintains Buy Rating for DocGo: Here’s What You Need To Know

By Benzinga Insights
September 19, 1:00 PM
BTIG has decided to maintain its Buy rating of DocGo (NASDAQ:DCGO) and lower its price target from $15.00…

DCGO

Posts pagination

Previous 1 … 6,743 6,744 6,745 … 19,074 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service